PubMed Nucleotide Protein Genome Structure PopSet Taxonomy OMIM

OMIM Update List for November, 2003

Please send your questions to the NCBI Help Desk.

November 29, 2003

New Entries:

300462 A-KINASE ANCHOR PROTEIN, 28-KD

Changed Entries:

608294 NONMETASTATIC CELLS 6, PROTEIN EXPRESSED IN; NME6

November 26, 2003

New Entries:

300460 PROTOCADHERIN 19; PCDH19
608272 NEURAMINIDASE 1; NEU1
608286 PROTOCADHERIN 10; PCDH10
608287 PROTOCADHERIN 18; PCDH18
608288 IGF2 mRNA-BINDING PROTEIN 1
608289 IGF2 mRNA-BINDING PROTEIN 2
608290 LELIS SYNDROME
608291 TUBULIN-TYROSINE LIGASE
608292 STOMATIN-LIKE PROTEIN 2; STOML2
608293 RHOGAP INTERACTING WITH CIP4 HOMOLOGS 1
608294 NONMETASTATIC CELLS 6, PROTEIN EXPRESSED IN; NME6

Changed Entries:

147470 INSULIN-LIKE GROWTH FACTOR II; IGF2
162200 NEUROFIBROMATOSIS, TYPE I; NF1
178500 PULMONARY FIBROSIS, IDIOPATHIC
178620 SURFACTANT, PULMONARY-ASSOCIATED PROTEIN C; SFTPC
178630 SURFACTANT, PULMONARY-ASSOCIATED PROTEIN A1; SFTPA1
178640 SURFACTANT, PULMONARY-ASSOCIATED PROTEIN B; SFTPB
190080 V-MYC AVIAN MYELOCYTOMATOSIS VIRAL ONCOGENE HOMOLOG; MYC
256550 NEURAMINIDASE DEFICIENCY
300292 FORKHEAD BOX P3; FOXP3
602198 CDK2-ASSOCIATED PROTEIN 1; CDK2AP1
603057 PROTOCADHERIN 16; PCDH16
603580 PROTOCADHERIN 8; PCDH8
604617 NEURAMINIDASE 3; NEU3
605325 CYTOCHROME P450, SUBFAMILY IIIA, POLYPEPTIDE 5; CYP3A5
605528 NEURAMINIDASE 2; NEU2
608272 NEURAMINIDASE 1; NEU1
608287 PROTOCADHERIN 18; PCDH18

November 25, 2003

New Entries:

608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS
608281 SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL
608282 TRACE AMINE RECEPTOR 3
608283 KINESIN FAMILY MEMBER 21A; KIF21A
608284 INTRAMEMBRANE PROTEASE 5
608285 NAD SYNTHETASE 1

Changed Entries:

106700 TOTAL ANOMALOUS PULMONARY VENOUS RETURN; TAPVR1
107400 PROTEASE INHIBITOR 1; PI
120070 COLLAGEN, TYPE IV, ALPHA-3; COL4A3
132900 AORTIC ANEURYSM, THORACIC
163800 NODAL RHYTHM
181750 SCLERODERMA, FAMILIAL PROGRESSIVE
191040 TROPONIN C, SLOW; TNNC1
203100 OCULOCUTANEOUS ALBINISM, TYPE I; OCA1
217980 CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
268850 SAO PAULO MCA/MR SYNDROME
300008 CHLORIDE CHANNEL 5; CLCN5
300248 INHIBITOR OF KAPPA LIGHT POLYPEPTIDE GENE ENHANCER IN B CELLS, KINASE
600163 SODIUM CHANNEL, VOLTAGE-GATED, TYPE V, ALPHA SUBUNIT; SCN5A
600994 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5; DFNA5
601653 EYES ABSENT 1; EYA1
604210 CRUMBS, DROSOPHILA, HOMOLOG OF, 1; CRB1
606652 T-CELL IMMUNOGLOBULIN- AND MUCIN-DOMAIN-CONTAINING MOLECULE 3
608136 RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10
608254 PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1-LIKE; PAXIP1L
608259 IGF2 mRNA-BINDING PROTEIN 3
608281 SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL
608282 TRACE AMINE RECEPTOR 3
608283 KINESIN FAMILY MEMBER 21A; KIF21A
Mini-MIM for 107400 PROTEASE INHIBITOR 1; PI

November 24, 2003

New Entries:

608280 GROWTH ARREST-SPECIFIC 5; GAS5

Changed Entries:

104614 SOLUTE CARRIER FAMILY 3 (CYSTINE, DIBASIC, AND NEUTRAL AMINO ACID
107400 PROTEASE INHIBITOR 1; PI
133540 EXCISION-REPAIR CROSS-COMPLEMENTING RODENT REPAIR DEFICIENCY, COMPLEMENTATION
137181 GAMMA-GLUTAMYLTRANSFERASE 2; GGT2
139320 GNAS COMPLEX LOCUS; GNAS
141900 HEMOGLOBIN--BETA LOCUS; HBB
152390 ARACHIDONATE 5-LIPOXYGENASE; ALOX5
180849 RUBINSTEIN-TAYBI SYNDROME; RSTS
181500 SCHIZOPHRENIA; SCZD
182900 SPHEROCYTOSIS, HEREDITARY; HS
182990 SPINAL INTRADURAL ARACHNOID CYSTS
220100 CYSTINURIA; CSNU
278700 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
300108 DIAPHANOUS, DROSOPHILA, HOMOLOG OF, 2; DIAPH2
600140 CREB-BINDING PROTEIN; CREBBP
600807 ASTHMA
600918 CYSTINURIA, TYPE III; CSNU3
603554 OMENN SYNDROME
605781 RAS HOMOLOG GENE FAMILY, MEMBER D; ARHD

November 21, 2003

New Entries:

608275 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 15;
608276 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 16;
608277 B-CELL RAG-ASSOCIATED GENE
Clinical Synopsis for 608180 SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL
Clinical Synopsis for 608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL
Clinical Synopsis for 608236 SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT

Changed Entries:

124910 DEAFNESS, LOW-FREQUENCY HEARING LOSS, MIXED CONDUCTIVE-SENSORINEURAL
136620 FRAGILE SITE 10q25
146680 INSULIN-DEGRADING ENZYME; IDE
180930 SALIVARY PROTEIN I; SAL-I
190195 TRANSGLUTAMINASE 1; TGM1
203200 OCULOCUTANEOUS ALBINISM, TYPE II; OCA2
214500 CHEDIAK-HIGASHI SYNDROME; CHS
300500 ALBINISM, OCULAR, TYPE I; OA1
600185 BREAST CANCER 2 GENE; BRCA2
602689 FASCIN, SEA URCHIN, HOMOLOG OF, 1; FSCN1
602911 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, GAMMA-2 SUBUNIT; CACNG2
604952 KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC
604953 KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR, TWO DOMAINS, SHORT CYTOPLASMIC
605526 ALZHEIMER DISEASE 6
606677 LECTIN, C-TYPE, SUPERFAMILY MEMBER 11; CLECSF11
607525 ZINC RIBBON DOMAIN-CONTAINING PROTEIN 1; ZNRD1
608177 EXOSTOSIN 1; EXT1
Clinical Synopsis for 132600 PILOMATRIXOMA
Clinical Synopsis for 153000 LYMPHEDEMA AND PTOSIS
Clinical Synopsis for 153100 LYMPHEDEMA, HEREDITARY, I
Clinical Synopsis for 153200 LYMPHEDEMA, HEREDITARY, II
Clinical Synopsis for 153300 YELLOW NAIL SYNDROME
Clinical Synopsis for 153400 LYMPHEDEMA-DISTICHIASIS SYNDROME
Clinical Synopsis for 305600 FOCAL DERMAL HYPOPLASIA; DHOF
Clinical Synopsis for 608180 SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL

November 20, 2003

New Entries:

608273 INTERLEUKIN 30; IL30
608274 PROTEIN ARGININE N-METHYLTRANSFERASE 6

Changed Entries:

123580 CRYSTALLIN, ALPHA-A; CRYAA
156000 MENIERE DISEASE
164040 NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 1; NPM1
166500 OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
189933 TRANSFER RNA THREONINE 2; TRT2
252500 MUCOLIPIDOSIS II
300373 OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
300402 LEUCINE ZIPPER, DOWNREGULATED IN CANCER 1; LDOC1
600555 SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1; STAT1
600899 PROTEIN KINASE, DNA-ACTIVATED, CATALYTIC SUBUNIT; PRKDC
601369 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 9; DFNA9
601457 SEVERE COMBINED IMMUNODEFICIENCY, B CELL-NEGATIVE
603196 COCHLIN; COCH
605350 T-CELL CYTOKINE RECEPTOR
605816 EPSTEIN-BARR VIRUS-INDUCED GENE 3; EBI3
606686 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 1; EIF2B1
606687 EUKARYOTIC TRANSLATION INITIATION FACTOR 2B, SUBUNIT 4; EIF2B4
606746 CHROMOSOME 19 OPEN READING FRAME 10; C19ORF10
607462 DRPLA GENE; DRPLA
608209 DIPEPTIDYL PEPTIDASE X; DPP10

November 19, 2003

New Entries:

608269 SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER),
608270 THREONINE ASPARTASE 1
608271 MICROTUBULE-ACTIN CROSS-LINKING FACTOR 1; MACF1

Changed Entries:

102578 ACUTE PROMYELOCYTIC LEUKEMIA, INDUCER OF; PML
130130 ELASTASE 2; ELA2
136352 FMS-LIKE TYROSINE KINASE 4; FLT4
152800 LYMPHANGIECTASIA, INTESTINAL
153100 LYMPHEDEMA, HEREDITARY, I
153200 LYMPHEDEMA, HEREDITARY, II
153400 LYMPHEDEMA-DISTICHIASIS SYNDROME
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
163950 NOONAN SYNDROME 1; NS1
173410 PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB
180240 RETINOIC ACID RECEPTOR, ALPHA; RARA
180849 RUBINSTEIN-TAYBI SYNDROME; RSTS
180850 MOVED TO 180849
191700 URIC ACID UROLITHIASIS
248800 MARINESCO-SJOGREN SYNDROME; MSS
600005 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, TRANSACTIVATOR; MHC2TA
600140 CREB-BINDING PROTEIN; CREBBP
601411 SARCOGLYCAN, DELTA; SGCD
602402 FORKHEAD BOX C2; FOXC2
602771 RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1
603868 RAS-ASSOCIATED PROTEIN RAB27A; RAB27A
604676 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, GENE P5-1
604886 COX4, NEIGHBOR OF; NOC4
605865 TASTE RECEPTOR TYPE 1, MEMBER 3; TAS1R3
606225 TASTE RECEPTOR TYPE 1, MEMBER 1; TAS1R1
606226 TASTE RECEPTOR TYPE 1, MEMBER 2; TAS1R2
606847 TCOF1 GENE
Clinical Synopsis for 129500 ECTODERMAL DYSPLASIA 2, HIDROTIC; ED2
Clinical Synopsis for 168500 PARIETAL FORAMINA; PFM
Clinical Synopsis for 305100 ECTODERMAL DYSPLASIA 1, ANHIDROTIC; ED1

November 18, 2003

New Entries:

300459 TENOMODULIN
608266 PARATHYROID CARCINOMA
608267 RAS-RELATED GTP-BINDING PROTEIN C; RRAGC
608268 RAS-RELATED GTP-BINDING PROTEIN D; RRAGD

Changed Entries:

105800 ANEURYSM, INTRACRANIAL BERRY
114290 CAMPOMELIC DYSPLASIA
116790 CATECHOL-O-METHYLTRANSFERASE; COMT
139393 GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS
164761 REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
173410 PLATELET-DERIVED GROWTH FACTOR RECEPTOR, BETA; PDGFRB
192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC; CMH
194050 WILLIAMS-BEUREN SYNDROME; WBS
224300 DYSOSTEOSCLEROSIS
252800 ALPHA-L-IDURONIDASE; IDUA
300005 METHYL-CpG-BINDING PROTEIN 2; MECP2
313450 SURFACE ANTIGEN, X-LINKED; SAX
313460 SURFACE ANTIGEN, X-LINKED, SECOND; SAX2
313470 CD99 ANTIGEN; CD99
601071 DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
602225 CONE-ROD HOMEO BOX-CONTAINING GENE; CRX
602849 MUENKE SYNDROME
603681 OTOFERLIN; OTOF
603708 MOLYBDENUM COFACTOR SYNTHESIS 2; MOCS2
603917 EUKARYOTIC TRANSLATION INITIATION FACTOR 3, SUBUNIT 9; EIF3S9
604148 SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER),
604159 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, GLYCINE), MEMBER
606157 PANTOTHENATE KINASE 2; PANK2
607093 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607393 HYPERPARATHYROIDISM 2 GENE; HRPT2
608232 LEUKEMIA, CHRONIC MYELOID; CML
608266 PARATHYROID CARCINOMA
Clinical Synopsis for 313450 SURFACE ANTIGEN, X-LINKED; SAX
Clinical Synopsis for 313460 SURFACE ANTIGEN, X-LINKED, SECOND; SAX2
Clinical Synopsis for 313470 CD99 ANTIGEN; CD99

November 17, 2003

New Entries:

608244 OTOSCLEROSIS 3; OTSC3
608254 PAX TRANSCRIPTION ACTIVATION DOMAIN-INTERACTING PROTEIN 1-LIKE; PAXIP1L
608257 MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT
608259 IGF-II mRNA-BINDING PROTEIN 3
608262 DISRUPTED IN RENAL CARCINOMA 3; DIRC3
608263 HEAT-SHOCK 27-KD PROTEIN-ASSOCIATED PROTEIN 1; HSPBAP1

Changed Entries:

109135 AXL RECEPTOR TYROSINE KINASE; AXL
109195 BACTERICIDAL PERMEABILITY-INCREASING PROTEIN; BPI
113970 BURKITT LYMPHOMA; BL
133090 ERYTHROCYTE SURFACE PROTEIN BAND 7.2; EPB72
136350 FIBROBLAST GROWTH FACTOR RECEPTOR 1; FGFR1
139320 GNAS COMPLEX LOCUS; GNAS
144700 RENAL CELL CARCINOMA 1; RCC1
147220 IMMUNOGLOBULIN LAMBDA CONSTANT REGION 1; IGLC1
147470 INSULIN-LIKE GROWTH FACTOR II; IGF2
155240 THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
158250 MOSAICISM, CHROMOSOMAL
166800 OTOSCLEROSIS; OTSC1
173490 PLATELET-DERIVED GROWTH FACTOR RECEPTOR, ALPHA; PDGFRA
176270 PRADER-WILLI SYNDROME; PWS
176640 PRION PROTEIN; PRNP
180240 RETINOIC ACID RECEPTOR, ALPHA; RARA
180860 SILVER-RUSSELL SYNDROME; SRS
189980 ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1
190040 PLATELET-DERIVED GROWTH FACTOR, BETA POLYPEPTIDE; PDGFB
191350 DOLICHYL-PHOSPHATE N-ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE; DPAGT1
300006 CENTRIN, EF-HAND PROTEIN, 2; CETN2
475000 GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
600080 MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC
600185 BREAST CANCER 2 GENE; BRCA2
600807 ASTHMA
600861 REGULATOR OF G PROTEIN SIGNALING 2; RGS2
601021 NUCLEOPORIN, 98-KD; NUP98
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601199 CALCIUM-SENSING RECEPTOR; CASR
601554 T-COMPLEX-ASSOCIATED-TESTES-EXPRESSED 1-LIKE 1; TCTEL1
601565 INTERFERON CONSENSUS SEQUENCE-BINDING PROTEIN 1; ICSBP1
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601844 PROTEIN KINASE, LYSINE-DEFICIENT 4; PRKWNK4
601999 LIM HOMEO BOX GENE 1; LHX1
602469 FOLATE RECEPTOR 3; FOLR3
602773 DISRUPTED IN RENAL CARCINOMA 2; DIRC2
602918 PHENYLALANINE-tRNA SYNTHETASE-LIKE; FARSL
602919 DOCKING PROTEIN 1; DOK1
603030 TOLL-LIKE RECEPTOR 4; TLR4
603128 SINGLE-MINDED, DROSOPHILA, HOMOLOG OF, 1; SIM1
603233 PSEUDOHYPOPARATHYROIDISM, TYPE IB
603244 HEPARAN SULFATE D-GLUCOSAMINYL 3-O-SULFOTRANSFERASE 1; HS3ST1
603759 LIM HOMEO BOX GENE 2; LHX2
604686 A-KINASE ANCHOR PROTEIN 13; AKAP13
604997 DOCKING PROTEIN 2; DOK2
605118 SUPPRESSOR OF CYTOKINE SIGNALING 4; SOCS4
605141 PRE-B-LYMPHOCYTE GENE 1; VPREB1
605727 OTOSCLEROSIS 2; OTSC2
606109 IMMUNOGENIC TUMOR ANTIGEN CML66
606423 DISRUPTED IN RENAL CARCINOMA 1; DIRC1
606764 GASTROINTESTINAL STROMAL TUMOR; GIST
608259 IGF-II mRNA-BINDING PROTEIN 3

November 14, 2003

New Entries:

608224 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 41; DFNA41
608260 POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 8; KCNH8
608261 SENTRIN-SPECIFIC PROTEASE 2
608264 DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40; DFNB40
608265 DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39; DFNB39

Changed Entries:

100820 ACHOO SYNDROME
106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A; CMT2A
119530 OROFACIAL CLEFT 1; OFC1
120260 COLLAGEN, TYPE IX, ALPHA-2; COL9A2
123101 MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 2; MSX2
141900 HEMOGLOBIN--BETA LOCUS; HBB
157300 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
164011 NUCLEAR FACTOR KAPPA-B, SUBUNIT 1; NFKB1
176310 PRE-B-CELL LEUKEMIA TRANSCRIPTION FACTOR 1; PBX1
179600 RAYNAUD DISEASE
180420 RIBONUCLEIC ACID, RIBOSOMAL, 5S
186880 T-CELL ANTIGEN RECEPTOR, ALPHA SUBUNIT; TCRA
192070 UV DAMAGE, EXCISION REPAIR OF, UV-24
214700 CHLORIDE DIARRHEA, FAMILIAL; CLD
229700 FRUCTOSE-1,6-BISPHOSPHATASE 1; FBP1
253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1
253400 SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
253550 SPINAL MUSCULAR ATROPHY, TYPE II; SMA2
264700 PSEUDOVITAMIN D DEFICIENCY RICKETS
306955 HETEROTAXY, VISCERAL, X-LINKED
600943 COLLAGEN-BINDING PROTEIN 2; CBP2
601168 DIHYDROPYRIMIDINASE-LIKE 3; DPYSL3
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS
601556 ATAXIN 1; ATX1
601873 BETA-1,4-N-ACETYLGALACTOSAMINYLTRANSFERASE; GALGT
602231 SMT3, YEAST, HOMOLOG 1; SMT3H1
602837 DNAJ, E. COLI, HOMOLOG OF, SUBFAMILY A, MEMBER 1; DNAJA1
603516 SPINOCEREBELLAR ATAXIA 10; SCA10
603851 PAIRED-LIKE HOMEO BOX 2B; PHOX2B
604305 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS II, DQ BETA-1; HLA-DQB1
605376 HETEROTAXY, VISCERAL, AUTOSOMAL
605444 HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN G-T
605981 UBIQUITIN-PROTEIN LIGASE E3 COMPONENT N-RECOGNIN 1; UBR1
606092 DOPAMINE RECEPTOR-INTERACTING PROTEIN, 78-KD
606111 MELANIN-CONCENTRATING HORMONE RECEPTOR 2
606624 NEUROGENIN 2; NEUROG2
606873 HEXOSAMINIDASE B; HEXB
607645 D4S234E GENE; D4S234E
608224 DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 41; DFNA41
608264 DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40; DFNB40
608265 DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39; DFNB39
Clinical Synopsis for 601596 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C

November 13, 2003

New Entries:

608232 LEUKEMIA, CHRONIC MYELOID; CML
608236 SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT
608252 ACTIN FILAMENT-ASSOCIATED PROTEIN
608253 TESTIS-SPECIFIC KINASE SUBSTRATE
608255 TRAF3-INTERACTING JNK-ACTIVATING MODULATOR
608256 SODIUM CHANNEL, VOLTAGE-GATED, TYPE IV, BETA SUBUNIT; SCN4B
608258 DIPEPTIDYL PEPTIDASE IX; DPP9

Changed Entries:

102981 ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE 1, RECEPTOR FOR; ADCYAP1R1
113705 BREAST CANCER 1 GENE; BRCA1
118200 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
124080 CYTOCHROME P450, SUBFAMILY XIB, POLYPEPTIDE 2; CYP11B2
139191 GROWTH HORMONE-RELEASING HORMONE RECEPTOR; GHRHR
151410 BREAKPOINT CLUSTER REGION; BCR
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
161950 IgA NEPHROPATHY
163950 NOONAN SYNDROME 1; NS1
175200 PEUTZ-JEGHERS SYNDROME; PJS
182230 SEPTOOPTIC DYSPLASIA
189980 ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1; ABL1
193300 VON HIPPEL-LINDAU SYNDROME; VHL
235200 HEMOCHROMATOSIS; HFE
276903 MYOSIN VIIA; MYO7A
312750 RETT SYNDROME; RTT
600035 EMPTY SPIRACLES, DROSOPHILA, 2, HOMOLOG OF; EMX2
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601264 MOVED TO 601271
601271 GUANYLATE CYCLASE ACTIVATOR 2B; GUCA2B
601596 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C
601802 HOMEO BOX GENE EXPRESSED IN ES CELLS; HESX1
601896 TNF RECEPTOR-ASSOCIATED FACTOR 3; TRAF3
602751 BTB AND CNC HOMOLOGY 1; BACH1
603205 MICRORCHIDIA, MOUSE, HOMOLOG OF
603482 BETA-TRANSDUCIN REPEAT-CONTAINING PROTEIN; BTRC
605608 CLAUDIN 14; CLDN14
605805 DERMATITIS, ATOPIC, 4; ATOD4
605844 DERMATITIS, ATOPIC, 5; ATOD5
606464 HEPCIDIN ANTIMICROBIAL PEPTIDE; HAMP
606652 T-CELL IMMUNOGLOBULIN- AND MUCIN-DOMAIN-CONTAINING MOLECULE 3
606819 DIPEPTIDYL PEPTIDASE VIII; DPP8
608136 RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 10; ARHGEF10
608206 KIAA1985
Clinical Synopsis for 180849 RUBINSTEIN-TAYBI SYNDROME; RSTS

November 12, 2003

New Entries:

608251 PHOBIA, SPECIFIC

Changed Entries:

109270 SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1
114480 BREAST CANCER
137570 SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 1; SLC20A1
139080 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, GRAVES DISEASE AUTOANTIGEN),
148059 KERATIN 7; KRT7
158378 SOLUTE CARRIER FAMILY 20 (PHOSPHATE TRANSPORTER), MEMBER 2; SLC20A2
167870 PANIC DISORDER
182308 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
190315 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, CITRATE TRANSPORTER),
193001 SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE TRANSPORTER), MEMBER
193002 SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE TRANSPORTER), MEMBER
203300 HERMANSKY-PUDLAK SYNDROME; HPS
239100 HYPEROSTOSIS CORTICALIS GENERALISATA
242300 ICHTHYOSIS, LAMELLAR, 1; LI1
300079 BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 4; BIRC4
300104 GDP DISSOCIATION INHIBITOR 1; GDI1
300242 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, BRAIN), MEMBER 14;
314375 SOLUTE CARRIER FAMILY 35 (UDP-GALACTOSE TRANSPORTER), MEMBER 2; SLC35A2
600336 SOLUTE CARRIER FAMILY 18 (VESICULAR MONOAMINE TRANSPORTER), MEMBER
600424 SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 1; SLC19A1
600767 GDP-DISSOCIATION INHIBITOR 2; GDI2
601460 SOLUTE CARRIER FAMILY 21 (PROSTAGLANDIN TRANSPORTER), MEMBER 2; SLC21A2
601611 SOLUTE CARRIER FAMILY 14 (UREA TRANSPORTER), MEMBER 2; SLC14A2
602339 SOLUTE CARRIER FAMILY 15 (OLIGOPEPTIDE TRANSPORTER), MEMBER 2; SLC15A2
602607 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 1; SLC22A1
602608 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 2; SLC22A2
602643 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 11B; TNFRSF11B
602655 SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1, ADAPTOR PROTEIN;
602883 SOLUTE CARRIER FAMILY 21 (ORGANIC ANION TRANSPORTER), MEMBER 3; SLC21A3
603080 SOLUTE CARRIER FAMILY 6 (NEUROTRANSMITTER TRANSPORTER, BETAINE/GABA),
603370 UDP-GLUCOSE DEHYDROGENASE; UGDH
603377 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 5; SLC22A5
603617 SOLUTE CARRIER FAMILY 24 (SODIUM/POTASSIUM/CALCIUM EXCHANGER), MEMBER
603667 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ARALAR), MEMBER 12;
603859 SOLUTE CARRIER FAMILY 25 (CITRIN), MEMBER 13; SLC25A13
603861 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, ORNITHINE TRANSPORTER),
603941 SOLUTE CARRIER FAMILY 19 (THIAMINE TRANSPORTER), MEMBER 2; SLC19A2
604024 SOLUTE CARRIER FAMILY 5 (SODIUM-DEPENDENT VITAMIN TRANSPORTER), MEMBER
604165 SOLUTE CARRIER FAMILY 25 (MITOCHONDRIAL CARRIER, OXOGLUTARATE CARRIER),
604190 SOLUTE CARRIER FAMILY 22 (ORGANIC CATION TRANSPORTER), MEMBER 4; SLC22A4
604216 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
604254 DYSLEXIA, SPECIFIC, 3; DYX3
604309 SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER),
604322 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
604842 SOLUTE CARRIER FAMILY 22 (EXTRANEURONAL MONOAMINE TRANSPORTER), MEMBER
604843 SOLUTE CARRIER FAMILY 21 (ORGANIC ANION TRANSPORTER), MEMBER 6; SLC21A6
604878 SOLUTE CARRIER FAMILY 12 (SODIUM/CHLORIDE TRANSPORTER), MEMBER 6;
604879 SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER
604988 SOLUTE CARRIER FAMILY 21, MEMBER 9 (ORGANIC ANION TRANSPORTER); SLC21A9
604995 SOLUTE CARRIER FAMILY 22 (ORGANIC ANION TRANSPORTER), MEMBER 7; SLC22A7
605024 SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER
605100 PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1, DELTA ISOFORM; PPM1D
605208 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
605245 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
605495 SOLUTE CARRIER FAMILY 21, MEMBER 8 (ORGANIC ANION TRANSPORTER); SLC21A8
605556 SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE TRANSPORTER-LIKE), MEMBER
605632 SOLUTE CARRIER FAMILY 35 (UDP-N-ACETYLGLUCOSAMINE TRANSPORTER), MEMBER
605634 SOLUTE CARRIER FAMILY 35 (CMP-SIALIC ACID TRANSPORTER), MEMBER 1;
606142 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
606145 SOLUTE CARRIER FAMILY 2 (FACILITATED GLUCOSE TRANSPORTER), MEMBER
606152 SOLUTE CARRIER FAMILY 19 (FOLATE TRANSPORTER), MEMBER 3; SLC19A3
606207 SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER),
606208 SOLUTE CARRIER FAMILY 28 (SODIUM-COUPLED NUCLEOSIDE TRANSPORTER),
606411 SOLUTE CARRIER FAMILY 13 (SODIUM-DEPENDENT DICARBOXYLATE TRANSPORTER),
606652 T-CELL IMMUNOGLOBULIN- AND MUCIN-DOMAIN-CONTAINING MOLECULE 3
606726 SOLUTE CARRIER FAMILY 12 (POTASSIUM/CHLORIDE TRANSPORTER), MEMBER
606757 SOLUTE CARRIER FAMILY 4 (SODIUM BICARBONATE COTRANSPORTER), MEMBER
606813 SOLUTE CARRIER FAMILY 2i (FACILITATED GLUCOSE TRANSPORTER), MEMBER
607093 5,10-@METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR
607190 REGULATOR OF G PROTEIN SIGNALING 13; RGS13
607261 ELLIS-VAN CREVELD SYNDROME GENE 2; EVC2
607563 SOLUTE CARRIER FAMILY 17 (SODIUM PHOSPHATE COTRANSPORTER), MEMBER
608058 ISLET-SPECIFIC GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT-RELATED PROTEIN
Clinical Synopsis for 258865 ORAL-FACIAL-DIGITAL SYNDROME WITH RETINAL ABNORMALITIES
Clinical Synopsis for 277170 VARADI-PAPP SYNDROME

November 11, 2003

New Entries:

608242 CYCLIN E-BINDING PROTEIN 1
608243 NECDIN-LIKE GENE 2; NDNL2
608245 KERATIN 6, INNER ROOT SHEATH, 1
608246 KERATIN 6, INNER ROOT SHEATH, 2
608247 KERATIN 6, INNER ROOT SHEATH, 3
608248 KERATIN 6, INNER ROOT SHEATH, 4
608249 CHROMOSOME 14 OPEN READING FRAME 18; C14ORF18
608250 SDS3, YEAST, HOMOLOG OF

Changed Entries:

110450 BLOOD GROUP--COLTON; CO
111400 BLOOD GROUP, P SYSTEM
112262 BONE MORPHOGENETIC PROTEIN 4; BMP4
120260 COLLAGEN, TYPE IX, ALPHA-2; COL9A2
120436 COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2
125520 DEPRESSOR ANGULI ORIS MUSCLE, HYPOPLASIA OF
135630 INTEGRIN, BETA-1; ITGB1
150330 LAMIN A/C; LMNA
156610 MICHELIN TIRE BABY SYNDROME
160775 MYOSIN, HEAVY CHAIN 9, NONMUSCLE; MYH9
163890 SYNUCLEIN, ALPHA; SNCA
168600 PARKINSON DISEASE; PD
173610 SELECTIN P; SELP
176960 PROTEIN KINASE C, ALPHA; PRKCA
189800 PREECLAMPSIA/ECLAMPSIA 1; PEE1
190685 DOWN SYNDROME
192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC; CMH
224700 EBSTEIN ANOMALY
253601 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B
277300 SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE, 1
301500 FABRY DISEASE
600204 EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
600363 SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
600639 CASPASE 2, APOPTOSIS-RELATED CYSTEINE PROTEASE; CASP2
602265 NEURAL PRECURSOR CELL EXPRESSED, DEVELOPMENTALLY DOWNREGULATED 9;
602574 TECTORIN, ALPHA; TECTA
602768 DELTA-LIKE 3; DLL3
602859 PEROXISOME BIOGENESIS FACTOR 10; PEX10
603094 UDP-GAL:BETA-GlcNAc BETA-1,3-GALACTOSYLTRANSFERASE, POLYPEPTIDE 3;
603360 PEROXISOME BIOGENESIS FACTOR 16; PEX16
603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21
605543 PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY; PARK4
607270 AUTS2 GENE; AUTS2
608046 HRD1, S. CEREVISIAE, HOMOLOG OF
608096 EPILEPSY, FAMILIAL TEMPORAL LOBE
608145 NONIMPRINTED GENE IN PRADER-WILLI SYNDROME/ANGELMAN SYNDROME CHROMOSOME
608156 NABLUS MASK-LIKE FACIAL SYNDROME

November 10, 2003

New Entries:

608235 GALACTOSE 3-O-SULFOTRANSFERASE 4
608237 GLYCOPROTEIN BETA-GALACTOSE 3-PRIME-SULFOTRANSFERASE
608238 SIGNAL PEPTIDE PEPTIDASE-LIKE 2A
608239 SIGNAL PEPTIDE PEPTIDASE-LIKE 2B
608240 SIGNAL PEPTIDE PEPTIDASE-LIKE 3
608241 SMAD NUCLEAR INTERACTING PROTEIN 1

Changed Entries:

102600 ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT
113700 BREASTS AND NIPPLES, ABSENCE OF
116952 CELL DIVISION CYCLE 42; CDC42
117550 SOTOS SYNDROME
120120 COLLAGEN, TYPE VII, ALPHA-1; COL7A1
120160 COLLAGEN, TYPE I, ALPHA-2; COL1A2
120360 MATRIX METALLOPROTEINASE 2; MMP2
128200 PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC
137580 GILLES DE LA TOURETTE SYNDROME; GTS
137800 GLIOMA OF BRAIN, FAMILIAL
141850 HEMOGLOBIN--ALPHA LOCUS 2; HBA2
141900 HEMOGLOBIN--BETA LOCUS; HBB
142871 HLA-G HISTOCOMPATIBILITY ANTIGEN, CLASS I; HLA-G
147557 INTEGRIN, BETA-4; ITGB4
147558 INTEGRIN, BETA-6; ITGB6
147620 INTERLEUKIN 6; IL6
151400 LEUKEMIA, CHRONIC LYMPHATIC; CLL
152200 APOLIPOPROTEIN(a); LPA
160000 MYOGLOBIN; MB
160800 MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
162200 NEUROFIBROMATOSIS, TYPE I; NF1
163730 NITRIC OXIDE SYNTHASE 2A; NOS2A
164160 LEPTIN; LEP
166220 OSTEOGENESIS IMPERFECTA, TYPE IV; OI4
166300 OSTEOLYSIS, HEREDITARY, OF CARPAL BONES WITH NEPHROPATHY
166700 BUSCHKE-OLLENDORFF SYNDROME
176640 PRION PROTEIN; PRNP
176860 PROTEIN C DEFICIENCY, CONGENITAL THROMBOTIC DISEASE DUE TO
180920 SALIVARY GLANDS, ABSENCE OF
183600 SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
186570 TARSAL-CARPAL COALITION SYNDROME; TCC
188360 THYMOCYTE ANTIGEN CD1B; CD1B
188570 THYROID HORMONE RESISTANCE
188580 THYROTOXIC PERIODIC PARALYSIS
190180 TRANSFORMING GROWTH FACTOR, BETA-1; TGFB1
190320 TRICHODENTOOSSEOUS SYNDROME
192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC; CMH
193210 INTEGRIN, ALPHA-V; ITGAV
193300 VON HIPPEL-LINDAU SYNDROME; VHL
203200 OCULOCUTANEOUS ALBINISM, TYPE II; OCA2
212500 CATARACT, CONGENITAL OR JUVENILE
238300 GLYCINE DECARBOXYLASE; GLDC
241850 HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
242650 PRIMARY CILIARY DYSKINESIA; PCD
245660 LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS
253000 MUCOPOLYSACCHARIDOSIS TYPE IVA
255700 MYOTONIA, GENERALIZED
256600 NEUROAXONAL DYSTROPHY, INFANTILE
257220 NIEMANN-PICK DISEASE, TYPE C1; NPC1
257800 OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION
268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE
270550 SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS
272650 TATSUMI FACTOR DEFICIENCY
276902 USHER SYNDROME, TYPE III; USH3
300034 ANGIOTENSIN II RECEPTOR, TYPE 2; AGTR2
300401 PROTEOLIPID PROTEIN 1; PLP1
301500 FABRY DISEASE
304400 DEAFNESS, CONDUCTIVE, WITH STAPES FIXATION
305600 FOCAL DERMAL HYPOPLASIA; DHOF
308380 INTERLEUKIN 2 RECEPTOR, GAMMA; IL2RG
309550 FRAGILE SITE MENTAL RETARDATION 1 GENE; FMR1
600528 CARNITINE PALMITOYLTRANSFERASE I, LIVER; CPT1A
600620 FK506-BINDING PROTEIN 1B; FKBP1B
600805 LAMININ, ALPHA-3; LAMA3
600900 SARCOGLYCAN, BETA; SGCB
601007 LEPTIN RECEPTOR; LEPR
601487 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PPARG
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601916 ARGININE-RICH, MUTATED IN EARLY STAGE TUMORS; ARMET
602067 CARDIOMYOPATHY, DILATED, 1F; CMD1F
602135 DYNEIN, AXONEMAL, LIGHT INTERMEDIATE POLYPEPTIDE 1; DNALI1
602229 SRY-BOX 10; SOX10
602553 ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION
602617 FORKHEAD BOX E1; FOXE1
602667 NBS1 GENE; NBS1
603107 TRANSCRIPTION FACTOR 20; TCF20
603932 INTERVERTEBRAL DISC DISEASE; IDD
604032 EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3; EIF2AK3
604387 NEPHRONOPHTHISIS 3; NPHP3
604569 CONTACTIN-ASSOCIATED PROTEIN-LIKE 2; CNTNAP2
604772 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC; CPVT
604889 NEUROBEACHIN; NBEA
605004 GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B
605283 MAGE-LIKE 2; MAGEL2
605725 PERIAXIN
606042 MYONEURIN; MYNN
606397 USH3A GENE; USH3A
606553 SOLUTE CARRIER FAMILY 9, ISOFORM 3, REGULATORY FACTOR 2; SLC9A3R2
606596 FUKUTIN-RELATED PROTEIN
606612 MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C
606784 GLYCOGEN SYNTHASE KINASE 3-ALPHA; GSK3A
607106 MINOR HISTOCOMPATIBILITY 13; HM13
607273 FOLLICULIN
608180 SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL
608234 GALACTOSE 3-O-SULFOTRANSFERASE 2
608235 GALACTOSE 3-O-SULFOTRANSFERASE 4

November 7, 2003

New Entries:

300458 MENTAL RETARDATION, X-LINKED 16; MRX16
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL
608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2
608234 GALACTOSE 3-O-SULFOTRANSFERASE 2

Changed Entries:

109684 17-@BETA-HYDROXYSTEROID DEHYDROGENASE I; HSD17B1
109685 17-@BETA-HYDROXYSTEROID DEHYDROGENASE II; HSD17B2
113705 BREAST CANCER 1 GENE; BRCA1
120820 COMPLEMENT COMPONENT 4B; C4B
120920 MEMBRANE COFACTOR PROTEIN; MCP
120940 COMPLEMENT COMPONENT 9; C9
133170 ERYTHROPOIETIN; EPO
134370 H FACTOR 1; HF1
136538 FORMYL PEPTIDE RECEPTOR-LIKE 1; FPRL1
138850 GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
140100 HAPTOGLOBIN; HP
141900 HEMOGLOBIN--BETA LOCUS; HBB
142409 HEPATOCYTE GROWTH FACTOR; HGF
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
145500 HYPERTENSION, ESSENTIAL
147558 INTEGRIN, BETA-6; ITGB6
147670 INSULIN RECEPTOR; INSR
152427 POTASSIUM CHANNEL, VOLTAGE-GATED, SUBFAMILY H, MEMBER 2; KCNH2
155100 MAY-HEGGLIN ANOMALY; MHA
158105 SMALL INDUCIBLE CYTOKINE A2; SCYA2
159440 MYELIN PROTEIN ZERO; MPZ
162151 PROPROTEIN CONVERTASE, SUBTILISIN/KEXIN-TYPE, 2; PCSK2
163729 NITRIC OXIDE SYNTHASE 3; NOS3
164860 MET PROTOONCOGENE; MET
167200 PACHYONYCHIA CONGENITA, TYPE 1; PC1
177900 PSORIASIS SUSCEPTIBILITY
188360 THYMOCYTE ANTIGEN CD1B; CD1B
191043 TROPONIN I, FAST-TWITCH SKELETAL MUSCLE ISOFORM; TNNI2
191092 TUBEROUS SCLEROSIS 2 GENE; TSC2
191740 UDP-GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1; UGT1A1
193300 VON HIPPEL-LINDAU SYNDROME; VHL
203300 HERMANSKY-PUDLAK SYNDROME; HPS
212750 CELIAC DISEASE; CD
219700 CYSTIC FIBROSIS; CF
224100 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II; CDAN2
235730 MOWAT-WILSON SYNDROME
242300 ICHTHYOSIS, LAMELLAR, 1; LI1
251280 MICROCEPHALY WITH SPASTIC QUADRIPLEGIA
264300 17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY
300005 METHYL-CpG-BINDING PROTEIN 2; MECP2
300046 MENTAL RETARDATION, X-LINKED 23; MRX23
300104 GDP DISSOCIATION INHIBITOR 1; GDI1
300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC
300268 ANGIONEUROTIC EDEMA, HEREDITARY, WITH NORMAL C1-INHIBITOR CONCENTRATION
300377 DYSTROPHIN; DMD
305900 GLUCOSE-6-PHOSPHATE DEHYDROGENASE; G6PD
309541 MENTAL RETARDATION, X-LINKED 3; MRX3
600374 BBS4 GENE; BBS4
600537 RECQ PROTEIN-LIKE; RECQL
601141 POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER
601174 IMIDAZOLINE RECEPTOR
601267 CHEMOKINE, CC MOTIF, RECEPTOR 2; CCR2
601293 RAS HOMOLOG ENRICHED IN BRAIN 2; RHEB2
601690 PHOSPHOLIPASE A2, GROUP VII; PLA2G7
601702 RHO-ASSOCIATED COILED-COIL-CONTAINING PROTEIN KINASE 1; ROCK1
601753 PEPTIDYL-PROLYL ISOMERASE D; PPID
601860 17-@BETA-HYDROXYSTEROID DEHYDROGENASE IV; HSD17B4
602151 DISHEVELLED 2; DVL2
602300 CEREBROSIDE SULFOTRANSFERASE
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602544 PARKIN; PARK2
603401 ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1
603728 NUMB, DROSOPHILA, HOMOLOG OF; NUMB
603886 ARTEMIN; ARTN
603968 POLYMERASE, DNA, ETA; POLH
604263 PRION GENE COMPLEX, DOWNSTREAM; PRND
604373 CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
604406 GUANINE NUCLEOTIDE-BINDING PROTEIN, ALPHA-13; GNA13
604443 FATTY ACID CoA LIGASE, LONG-CHAIN 6; FACL6
604566 ALG6, S. CEREVISIAE, HOMOLOG OF
604837 G PROTEIN-COUPLED RECEPTOR 44; GPR44
604982 HPS1 GENE; HPS1
605218 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
605570 RAS FAMILY, MEMBER RAB11A; RAB11A
606596 FUKUTIN-RELATED PROTEIN
606682 HPS4 GENE; HPS4
606981 GUANINE NUCLEOTIDE-BINDING PROTEIN, GAMMA-2; GNG2
607037 ENOYL-CoA HYDRATASE/3-HYDROXYACYL CoA DEHYDROGENASE; EHHADH
607113 APOLIPOPROTEIN B mRNA-EDITING ENZYME, CATALYTIC POLYPEPTIDE-LIKE 3G;
607508 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5
607522 HPS6 GENE
607542 POTASSIUM CHANNEL, VOLTAGE-GATED, KQT-LIKE SUBFAMILY, MEMBER 1; KCNQ1
607626 ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS
608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2

November 6, 2003

New Entries:

608180 SYNPOLYDACTYLY, 3/3-PRIME/4, ASSOCIATED WITH METACARPAL AND METATARSAL
608222 ADENYLOSUCCINATE LYASE; ADSL
608230 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1I SUBUNIT; CACNA1I
608231 CHROMOSOME 12 OPEN READING FRAME 2; C12ORF2

Changed Entries:

103050 ADENYLOSUCCINASE DEFICIENCY
109760 5-@HYDROXYTRYPTAMINE RECEPTOR 1A; HTR1A
111100 FUCOSYLTRANSFERASE 3; FUT3
111130 BLOOD GROUP--LKE; LKE
116790 CATECHOL-O-METHYLTRANSFERASE; COMT
118945 CILIARY NEUROTROPHIC FACTOR; CNTF
118946 CILIARY NEUROTROPHIC FACTOR RECEPTOR; CNTFR
120328 COLLAGEN, TYPE XVIII, ALPHA-1; COL18A1
122561 CORTICOTROPIN-RELEASING HORMONE RECEPTOR 1; CRHR1
123101 MUSCLE SEGMENT HOMEO BOX, DROSOPHILA, HOMOLOG OF, 2; MSX2
126375 DNA METHYLTRANSFERASE 1; DNMT1
133450 EWING SARCOMA BREAKPOINT REGION 1; EWSR1
134820 FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
135820 FIBULIN 1; FBLN1
136352 FMS-LIKE TYROSINE KINASE 4; FLT4
136530 FOLLICLE-STIMULATING HORMONE, BETA POLYPEPTIDE; FSHB
136535 FORMIN; FMN
136800 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL
138320 GLUTATHIONE PEROXIDASE; GPX1
138850 GONADOTROPIN-RELEASING HORMONE RECEPTOR; GNRHR
146110 HYPOGONADOTROPIC HYPOGONADISM
147720 INTERLEUKIN 1-BETA; IL1B
147760 INTERLEUKIN 1-ALPHA; IL1A
149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME
152760 GONADOTROPIN-RELEASING HORMONE 1; GNRH1
155255 MEDULLOBLASTOMA
159555 MYELOID/LYMPHOID OR MIXED LINEAGE LEUKEMIA; MLL
164160 LEPTIN; LEP
164230 OBSESSIVE-COMPULSIVE DISORDER 1; OCD1
164870 V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 2; ERBB2
168000 PARAGANGLIOMAS, FAMILIAL NONCHROMAFFIN, 1; PGL1
168600 PARKINSON DISEASE; PD
180200 RETINOBLASTOMA; RB1
181500 SCHIZOPHRENIA; SCZD
182100 FUCOSYLTRANSFERASE 2; FUT2
188360 THYMOCYTE ANTIGEN CD1B; CD1B
190070 V-KI-RAS2 KIRSTEN RAT SARCOMA 2 VIRAL ONCOGENE HOMOLOG; KRAS2
191190 TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY, MEMBER 1A; TNFRSF1A
193300 VON HIPPEL-LINDAU SYNDROME; VHL
203300 HERMANSKY-PUDLAK SYNDROME; HPS
205400 TANGIER DISEASE; TGD
208800 PYRUVATE DECARBOXYLASE DEFICIENCY
227200 EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC
235200 HEMOCHROMATOSIS; HFE
236000 HODGKIN LYMPHOMA
239000 PAGET DISEASE, JUVENILE
242860 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
248200 STARGARDT DISEASE 1; STGD1
248800 MARINESCO-SJOGREN SYNDROME; MSS
253260 BIOTINIDASE; BTD
256000 LEIGH SYNDROME; LS
266900 SENIOR-LOKEN SYNDROME
300096 TRANSMEMBRANE 4 SUPERFAMILY, MEMBER 2; TM4SF2
300210 MENTAL RETARDATION, X-LINKED 58; MRX58
300237 TRANSCRIPTION ELONGATION FACTOR A-LIKE 1; TCEAL1
300500 ALBINISM, OCULAR, TYPE I; OA1
305371 GATA-BINDING PROTEIN 1; GATA1
306250 COLONY-STIMULATING FACTOR 2 RECEPTOR, ALPHA; CSF2RA
312610 RETINITIS PIGMENTOSA GTPase REGULATOR; RPGR
600046 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600095 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
600140 CREB-BINDING PROTEIN; CREBBP
600263 HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
600510 GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
600882 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B
601097 PERIPHERAL MYELIN PROTEIN 22; PMP22
601204 PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PTGFRN
601232 PHOSPHATIDYLINOSITOL 3-KINASE, CATALYTIC, GAMMA; PIK3CG
601464 LYMPHOID NUCLEAR PROTEIN RELATED TO AF4; LAF4
601958 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, BETA-3 SUBUNIT; CACNB3
601980 LIPASE, GASTRIC; LIPF
602229 SRY-BOX 10; SOX10
602286 STEROL C5-DESATURASE-LIKE; SC5DL
602298 RAS-ASSOCIATED PROTEIN RAB7; RAB7
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602690 SUCCINATE DEHYDROGENASE COMPLEX, SUBUNIT D, INTEGRAL MEMBRANE PROTEIN;
603000 IMMATURE COLON CARCINOMA TRANSCRIPT 1; ICT1
603401 ADAPTOR-RELATED PROTEIN COMPLEX 3, BETA-1 SUBUNIT; AP3B1
604031 STEAROYL-CoA DESATURASE; SCD
604065 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1G SUBUNIT; CACNA1G
604155 LanC-LIKE 1; LANCL1
604161 G PROTEIN-COUPLED RECEPTOR 54; GPR54
605130 GROWTH DEFICIENCY AND MENTAL RETARDATION WITH FACIAL DYSMORPHISM
605203 MULTIPLE PTERYGIUM SYNDROME, ASLAN TYPE
605646 SOLUTE CARRIER FAMILY 26, MEMBER 4; SLC26A4
606515 RNA, 7SK SMALL NUCLEAR; RN7SK
606989 MYELOPEROXIDASE; MPO
607567 OLFACTOMEDIN 3; OLFM3
607619 NONERYTHROID PROTEIN 4.1, OVARY TYPE
607872 MONOSOMY 1p36 SYNDROME
607904 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, T TYPE, ALPHA-1H SUBUNIT; CACNA1H
607922 ALPHA-1,4-GALACTOSYLTRANSFERASE; A4GALT
608071 SHFM3 GENE; SHFM3
608231 CHROMOSOME 12 OPEN READING FRAME 2; C12ORF2

November 5, 2003

New Entries:

608220 SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE, WITH DISC HERNIATION
608228 NANOS, DROSOPHILA, HOMOLOG OF, 2
608229 NANOS, DROSOPHILA, HOMOLOG OF, 3

Changed Entries:

107741 APOLIPOPROTEIN E; APOE
110750 BLOOD GROUP--GERBICH; Ge
116960 MORTALITY FACTOR 4; MORF4
120270 COLLAGEN, TYPE IX, ALPHA-3; COL9A3
123890 CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4
127300 LERI-WEILL DYSCHONDROSTEOSIS; LWD
132700 CYLINDROMATOSIS, FAMILIAL; CYLD
133530 EXCISION-REPAIR, COMPLEMENTING DEFECTIVE, IN CHINESE HAMSTER, 5; ERCC5
134820 FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
135900 FIFTH DIGIT SYNDROME
138250 1-@PYRROLINE-5-CARBOXYLATE SYNTHETASE; PYCS
142800 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, A; HLA-A
147050 IgE RESPONSIVENESS, ATOPIC; IGER
147435 INDOLEAMINE 2,3-DIOXYGENASE; INDO
147840 INTERCELLULAR ADHESION MOLECULE 1; ICAM1
155555 MELANOCORTIN 1 RECEPTOR; MC1R
162080 NEURAL RETINA LEUCINE ZIPPER; NRL
162400 NEUROPATHY, HEREDITARY SENSORY, TYPE I; HSN1
163729 NITRIC OXIDE SYNTHASE 3; NOS3
174100 POLYDACTYLY, IMPERFORATE ANUS, AND VERTEBRAL ANOMALIES
203100 OCULOCUTANEOUS ALBINISM, TYPE I; OCA1
205900 DIAMOND-BLACKFAN ANEMIA; DBA
239000 PAGET DISEASE, JUVENILE
245000 PAPILLON-LEFEVRE SYNDROME; PALS
245010 HAIM-MUNK SYNDROME; HMS
249100 FAMILIAL MEDITERRANEAN FEVER; FMF
276710 TYROSINEMIA, TYPE III
300065 FSH PRIMARY RESPONSE, RAT, HOMOLOG OF, 1; FSHPRH1
300068 ANDROGEN INSENSITIVITY SYNDROME; AIS
300085 CONE DYSTROPHY, X-LINKED, 2; COD2
300110 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, ALPHA-1F SUBUNIT; CACNA1F
300600 ALBINISM, OCULAR, TYPE II; OA2
303800 COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD
304020 CONE DYSTROPHY, X-LINKED, 1; COD1
304800 DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED
308000 HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1
312080 PELIZAEUS-MERZBACHER DISEASE; PMD
312920 SPASTIC PARAPLEGIA 2, X-LINKED; SPG2
313700 ANDROGEN RECEPTOR; AR
314850 KELL BLOOD GROUP PRECURSOR; XK
600209 EXOSTOSES, MULTIPLE, TYPE III; EXT3
600887 MutS, E. COLI, HOMOLOG OF, 3; MSH3
601176 GLUTAMATE-CYSTEINE LIGASE, MODIFIER SUBUNIT; GCLM
602093 CONE DYSTROPHY 3; COD3
602365 CATHEPSIN C; CTSC
603029 TOLL-LIKE RECEPTOR 3; TLR3
603616 RABAPTIN 5; RABPT5
603680 SPINOCEREBELLAR ATAXIA 8; SCA8
603783 COGNITIVE ABILITY, GENERAL
604532 POLYCYSTIN 2-LIKE 1; PKD2L1
604581 ATPase FAMILY GENE 3-LIKE 2; AFG3L2
605147 LEUKOCYTE CELL-DERIVED CHEMOTAXIN 1; LECT1
605264 SORBIN AND SH3 DOMAIN CONTAINING 1; SORBS1
605337 FACTOR H-RELATED GENE 4; FHR4
605597 FORKHEAD TRANSCRIPTION FACTOR FOXL2; FOXL2
606397 USH3A GENE; USH3A
606597 PAIRED BOX GENE 3; PAX3
606690 LYMPHANGIOLEIOMYOMATOSIS; LAM
606765 THYROID PEROXIDASE; TPO
606933 TYROSINASE; TYR
607991 SOLUTE CARRIER FAMILY 8 (SODIUM-CALCIUM EXCHANGER), MEMBER 3; SLC8A3
608115 OVARIAN HYPERSTIMULATION SYNDROME
608194 CONE-ROD DYSTROPHY 9; CORD9
608225 UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE

November 4, 2003

New Entries:

608225 UDP-N-ACETYL-ALPHA-D-GALACTOSAMINE:POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE
608226 NANOS, DROSOPHILA, HOMOLOG OF, 1

Changed Entries:

152690 THYROID AUTOANTIGEN, 70-KD; G22P1
188455 THYROGLOSSAL DUCT CYST, FAMILIAL
189906 TRANSCRIPTION FACTOR Sp1; SP1
314550 VESICOURETERAL REFLUX, X-LINKED; VURX
600694 INTERLEUKIN 6 SIGNAL TRANSDUCER; IL6ST
600748 TESTIS-ENHANCED GENE TRANSCRIPT; TEGT
601221 TISSUE-SPECIFIC EXTINGUISHER 3
601234 NASCENT POLYPEPTIDE-ASSOCIATED COMPLEX, ALPHA POLYPEPTIDE; NACA
601897 ZINC FINGER PROTEIN 148; ZNF148
602542 BASIC TRANSCRIPTION FACTOR 3; BTF3
602544 PARKIN; PARK2
605281 DEAD/H BOX 4; DDX4
606085 TESTIS-DERIVED TRANSCRIPT; TES
606961 WW DOMAIN-BINDING PROTEIN 1; WBP1
606962 WW DOMAIN-BINDING PROTEIN 2; WBP2
607029 VESICLE-ASSOCIATED MEMBRANE PROTEIN 5; VAMP5
607205 PUMILIO, DROSOPHILA, HOMOLOG OF, 2; PUM2

November 3, 2003

New Entries:

608223 ASPIRIN RESISTANCE

Changed Entries:

100800 ACHONDROPLASIA; ACH
103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS
114205 CALCIUM CHANNEL, VOLTAGE-DEPENDENT, L TYPE, ALPHA-1C SUBUNIT; CACNA1C
114610 CANNABINOID RECEPTOR 1; CNR1
116806 CATENIN, BETA-1; CTNNB1
133780 EXUDATIVE VITREORETINOPATHY, FAMILIAL; EVR
134830 FIBRINOGEN, B BETA POLYPEPTIDE; FGB
153800 MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2
165640 ORNITHINE DECARBOXYLASE 1; ODC1
173470 INTEGRIN, BETA-3; ITGB3
191321 UBIQUITIN A-52-RESIDUE RIBOSOMAL PROTEIN FUSION PRODUCT; UBA52
193060 VIMENTIN; VIM
217100 CONSTRICTING BANDS, CONGENITAL
248610 MAPLE SYRUP URINE DISEASE, TYPE II
252800 ALPHA-L-IDURONIDASE; IDUA
300087 X INACTIVATION, FAMILIAL SKEWED, 1; SXI1
314670 X INACTIVATION-SPECIFIC TRANSCRIPT; XIST
600214 ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; AGER
600514 REELIN; RELN
600543 V-ERB-B2 AVIAN ERYTHROBLASTIC LEUKEMIA VIRAL ONCOGENE HOMOLOG 4; ERBB4
601276 ZINC FINGER PROTEIN 177; ZNF177
601545 PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE, ISOFORM 1B, ALPHA SUBUNIT;
601789 PEROXISOME BIOGENESIS FACTOR 13; PEX13
601796 TAF4 RNA POLYMERASE II, TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR,
601897 ZINC FINGER PROTEIN 148; ZNF148
602421 CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CFTR
602443 X-PROLYL AMINOPEPTIDASE 1; XPNPEP1
602483 EARS, PROMINENT AND CONSTRICTED
603164 PEROXISOME BIOGENESIS FACTOR 3; PEX3
603812 WD REPEAT-CONTAINING PROTEIN 22; WDR22
605100 PROTEIN PHOSPHATASE, MAGNESIUM-DEPENDENT, 1, DELTA ISOFORM; PPM1D
605300 ADAPTOR PROTEIN CONTAINING PH AND SH2 DOMAINS
606417 WD REPEAT-CONTAINING PROTEIN 11; WDR11
606749 TUBULOINTERSTITIAL NEPHRITIS ANTIGEN; TINAG
Clinical Synopsis for 194050 WILLIAMS-BEUREN SYNDROME; WBS

Disclaimer | Write to the Help Desk | Privacy Policy
NCBI | NLM | NIH